Cargando…
Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)
Background: Pulmonary arterial hypertension (PAH) is a malignant pulmonary vascular disease that negatively impacts quality of life, exercise capacity, and mortality. This study sought to investigate the relationship between serum uric acid (UA) level and the disease severity and treatment response...
Autores principales: | Luo, Jun, Li, Yuanchang, Chen, Jingyuan, Qiu, Haihua, Chen, Wenjie, Luo, Xiaoqin, Chen, Yusi, Tan, Yingjie, Li, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493272/ https://www.ncbi.nlm.nih.gov/pubmed/37701027 http://dx.doi.org/10.3389/fphar.2023.1238581 |
Ejemplares similares
-
Differences in right ventricular function and response to targeted therapy between patients with IPAH and PAH-CHD
por: Zhu, Tengteng, et al.
Publicado: (2023) -
The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study
por: Chen, Yusi, et al.
Publicado: (2022) -
Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study
por: Chen, Yusi, et al.
Publicado: (2022) -
Effect of multidisciplinary team (MDT) centred on pregnant women with pulmonary hypertension on treatment and outcomes of pregnancy
por: Chen, Wenjie, et al.
Publicado: (2023) -
Differential expression spectrum and targeted gene prediction of tRNA-derived small RNAs in idiopathic pulmonary arterial hypertension
por: Chen, Yusi, et al.
Publicado: (2023)